Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 241

1.

Histologic changes resembling acute rejection in a liver transplant patient treated with terbinafine.

Lovell MO, Speeg KV, Havranek RD, Sharkey FE.

Hum Pathol. 2003 Feb;34(2):187-9.

PMID:
12612888
2.

Terbinafine-induced acute autoimmune hepatitis in the setting of hepatitis B virus infection.

Paredes AH, Lewis JH.

Ann Pharmacother. 2007 May;41(5):880-4.

PMID:
17426078
3.

[Terbinafine-induced cholestatic liver injury].

Shiloah E, Horowiz M, Zecler E.

Harefuah. 1997 Jul;133(1-2):11-2, 80-1. Hebrew.

PMID:
9332048
4.

The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation.

Ludwig J, Wiesner RH, Batts KP, Perkins JD, Krom RA.

Hepatology. 1987 May-Jun;7(3):476-83.

PMID:
3552923
5.

Terbinafine-induced hepatic failure requiring liver transplantation.

Perveze Z, Johnson MW, Rubin RA, Sellers M, Zayas C, Jones JL, Cross R, Thomas K, Butler B, Shrestha R.

Liver Transpl. 2007 Jan;13(1):162-4.

6.
7.
8.
9.
10.

Vanishing bile-duct syndrome following liver transplantation--is it reversible?

Hubscher SG, Buckels JA, Elias E, McMaster P, Neuberger J.

Transplantation. 1991 May;51(5):1004-10.

PMID:
1851580
11.

Centrilobular histopathologic changes in liver transplant biopsies.

Khettry U, Backer A, Ayata G, Lewis WD, Jenkins RL, Gordon FD.

Hum Pathol. 2002 Mar;33(3):270-6.

PMID:
11979366
12.

Significance of central perivenulitis in pediatric liver transplantation.

Abraham SC, Freese DK, Ishitani MB, Krasinskas AM, Wu TT.

Am J Surg Pathol. 2008 Oct;32(10):1479-88. doi: 10.1097/PAS.0b013e31817a8e96.

PMID:
18708942
13.

Pathomorphological features of acute rejection in patients after orthotopic liver transplantation: own experience.

Górnicka B, Ziarkiewicz-Wróblewska B, Bogdańska M, Ołdakowska-Jedynak U, Wróblewski T, Morton M, Ziółkowski J, Paczek L, Krawczyk M, Wasiutyński A.

Transplant Proc. 2006 Jan-Feb;38(1):221-5.

PMID:
16504708
14.

Terbinafine-induced cholestatic liver disease.

Lazaros GA, Papatheodoridis GV, Delladetsima JK, Tassopoulos NC.

J Hepatol. 1996 Jun;24(6):753-6.

PMID:
8835752
15.
16.

Apoptosis of bile duct epithelial cells in hepatic allograft rejection.

Nawaz S, Fennell RH.

Histopathology. 1994 Aug;25(2):137-42.

PMID:
7982676
17.

Centrilobular necrosis after orthotopic liver transplantation: association with acute cellular rejection and impact on outcome.

Hassoun Z, Shah V, Lohse CM, Pankratz VS, Petrovic LM.

Liver Transpl. 2004 Apr;10(4):480-7. Erratum in: Liver Transpl. 2004 Jun;10(6):816.

18.

Severe ductopenic rejection with features of vanishing bile duct syndrome: clinical, biochemical, and histologic evidence for spontaneous resolution.

Noack KB, Wiesner RH, Batts K, van Hoek B, Ludwig J.

Transplant Proc. 1991 Feb;23(1 Pt 2):1448-51. No abstract available.

PMID:
1989260
19.

Progressive bile duct injury after thiabendazole administration.

Manivel JC, Bloomer JR, Snover DC.

Gastroenterology. 1987 Aug;93(2):245-9.

PMID:
3297909
20.

Pathology and biopsy diagnosis of the transplanted liver.

Portmann B, Slapak GI, Gane E, Williams R.

Verh Dtsch Ges Pathol. 1995;79:277-90. Review.

PMID:
8600691
Items per page

Supplemental Content

Support Center